Symbicort Pmdi



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Asthma 29.6%
Chronic Obstructive Pulmonary Disease 27.7%
Hypertension 8.3%
Gastrooesophageal Reflux Disease 5.6%
Anxiety 3.5%
Dyspnoea 2.9%
Depression 2.8%
Emphysema 2.4%
Sleep Disorder 2.1%
Blood Pressure Abnormal 1.9%
Blood Cholesterol Abnormal 1.9%
Pain 1.9%
Cardiac Disorder 1.7%
Blood Cholesterol Increased 1.5%
Thyroid Disorder 1.2%
Diabetes Mellitus 1.1%
Multiple Allergies 1.1%
Back Pain 1.0%
Hypersensitivity 1.0%
Wheezing 1.0%
Dyspnoea 20.2%
Intentional Drug Misuse 9.5%
Malaise 9.0%
Off Label Use 7.8%
Chronic Obstructive Pulmonary Disease 6.4%
Pneumonia 6.2%
Wheezing 6.2%
Visual Impairment 4.1%
Asthma 3.6%
Drug Dose Omission 3.4%
Respiratory Disorder 3.4%
Nasopharyngitis 2.4%
Sinusitis 2.4%
Weight Decreased 2.4%
Death 2.3%
Lung Disorder 2.3%
Vomiting 2.3%
Weight Increased 2.3%
Tremor 2.0%
Emphysema 1.8%
Secondary
Asthma 35.2%
Chronic Obstructive Pulmonary Disease 25.5%
Gastrooesophageal Reflux Disease 5.4%
Hypertension 4.9%
Emphysema 3.6%
Anxiety 2.2%
Bipolar Disorder 2.2%
Dyspnoea 2.1%
Bronchitis 2.0%
Blood Cholesterol Abnormal 1.9%
Depression 1.9%
Blood Pressure Abnormal 1.8%
Wheezing 1.7%
Bronchitis Chronic 1.5%
Sleep Disorder 1.5%
Bronchiectasis 1.4%
Multiple Allergies 1.4%
Cardiac Disorder 1.3%
Pain 1.3%
Cough 1.2%
Off Label Use 18.3%
Intentional Drug Misuse 11.4%
Wheezing 9.9%
Dyspnoea 5.9%
Visual Impairment 5.9%
Pneumonia 4.8%
Sleep Disorder Due To General Medical Condition, Insomnia Type 4.8%
Syncope 4.4%
Malaise 4.0%
Vomiting 4.0%
Weight Increased 3.7%
Pruritus 3.3%
Weight Decreased 3.3%
Tremor 2.9%
Upper-airway Cough Syndrome 2.9%
Oropharyngeal Pain 2.6%
Death 2.2%
Pulmonary Congestion 2.2%
Circumstance Or Information Capable Of Leading To Medication Error 1.8%
Osteoarthritis 1.8%